Low-frequency ultrasound-induced VEGF suppression and synergy with dendritic cell-mediated anti-tumor immunity in murine prostate cancer cells in vitro

[1]  R. Figlin,et al.  Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma , 2016, Journal of Immunotherapy for Cancer.

[2]  J. van Ryn,et al.  Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment , 2016, Oncotarget.

[3]  Jinwoo Hong,et al.  Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy , 2016, Oncotarget.

[4]  Z. Zeng,et al.  Biophysical Properties and Motility of Human Mature Dendritic Cells Deteriorated by Vascular Endothelial Growth Factor through Cytoskeleton Remodeling , 2016, International journal of molecular sciences.

[5]  K. Tachibana,et al.  Study of cellular response induced by low intensity ultrasound frequency sweep pattern on myelomonocytic lymphoma U937 cells , 2016, Journal of Ultrasound.

[6]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[7]  F. Vera-Badillo,et al.  Immunotherapy in prostate cancer: review of the current evidence , 2015, Clinical and Translational Oncology.

[8]  V. Schirrmacher,et al.  Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report , 2014, Oncology letters.

[9]  G. Ehninger,et al.  Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody‐based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells , 2014, The Prostate.

[10]  Z. Berneman,et al.  Clinical use of dendritic cells for cancer therapy. , 2014, The Lancet. Oncology.

[11]  Chih-Kuang Yeh,et al.  Combining Microbubbles and Ultrasound for Drug Delivery to Brain Tumors: Current Progress and Overview , 2014, Theranostics.

[12]  Bing Hu,et al.  Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice. , 2013, Oncology reports.

[13]  Bing Hu,et al.  Sonoporation by low-frequency and low-power ultrasound enhances chemotherapeutic efficacy in prostate cancer cells in vitro , 2013, Oncology letters.

[14]  Sung Dae Kim,et al.  Effect of Low dose Radiation on Differentiation of Bone Marrow Cells into Dendritic Cells , 2013, Dose-response : a publication of International Hormesis Society.

[15]  Zhang Jianwei,et al.  4-1BB Protects Dendritic Cells from Prostate Cancer-Induced Apoptosis , 2013, Pathology & Oncology Research.

[16]  T. H. van der Kwast,et al.  EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. , 2011, European urology.

[17]  T. H. van der Kwast,et al.  [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]. , 2011, Actas urologicas espanolas.

[18]  P. Kantoff,et al.  Sipuleucel-T immunotherapy for castration-resistant prostate cancer. , 2010, The New England journal of medicine.

[19]  X. Ju,et al.  Review of human DC subtypes. , 2010, Methods in molecular biology.

[20]  G. Hämmerling,et al.  Review of murine dendritic cells: types, location, and development. , 2010, Methods in molecular biology.

[21]  C. Holterman,et al.  Human cancers converge at the HIF-2α oncogenic axis , 2009, Proceedings of the National Academy of Sciences.

[22]  K. Tachibana,et al.  Evaluation and comparison of three novel microbubbles: enhancement of ultrasound-induced cell death and free radicals production. , 2009, Ultrasonics sonochemistry.

[23]  Michel Bolla,et al.  [EAU guidelines on prostate cancer]. , 2009, Actas urologicas espanolas.

[24]  K. Tachibana,et al.  Genetic networks responsive to low-intensity pulsed ultrasound in human lymphoma U937 cells. , 2008, Cancer letters.

[25]  W. O’Brien.  Ultrasound-biophysics mechanisms. , 2007, Progress in biophysics and molecular biology.

[26]  Michael D Feldman,et al.  The antivascular action of physiotherapy ultrasound on murine tumors. , 2005, Ultrasound in medicine & biology.

[27]  Lawrence A Crum,et al.  Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo. , 2005, Ultrasound in medicine & biology.

[28]  Federación de Sociedades Españolas de Oncología.  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. , 2005 .

[29]  William J Catalona,et al.  Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. , 2004, The Journal of urology.

[30]  Stefania Gallucci,et al.  Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.

[31]  S. Kaul,et al.  Interactions between microbubbles and ultrasound: in vitro and in vivo observations. , 1997, Journal of the American College of Cardiology.

[32]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[33]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.